224 articles in this topic
New study shows DunedinPACE aging biomarker can predict who will develop metabolic syndrome years in advance, outperforming other epigenetic clocks.
Expert consensus provides updated recommendations for managing popular weight-loss medications before and after surgery.
New review explains the dual mechanisms behind GLP-1 receptor agonists' dramatic weight loss effects in both central and peripheral systems.
Meta-analysis reveals patients regain substantial weight after discontinuing semaglutide, tirzepatide, and liraglutide therapy.
New research reveals how maltol, a widely used food flavoring, may weaken bones in diabetic patients by disrupting bone remodeling.
New review reveals how saturated fat-rich diets trigger neuroinflammation and cognitive decline, but offers actionable prevention strategies.
New research shows combining weight-loss medications with hormone therapy could transform health outcomes for obese men with low testosterone.
New research reveals how metabolic syndrome dramatically increases disease risk, but lifestyle interventions can halt and reverse progression.
Restoring mitochondrial complex I function in fat cells prevents obesity-related metabolic dysfunction, even without weight loss.
New research reveals why motivation matters early but emotional eating becomes the key barrier later in weight loss programs.
Combining phentermine-topiramate with digital lifestyle coaching produced 15kg weight loss and reduced heart disease risk over 12 months.
New research reveals how sleep patterns influence long-term weight control and food cravings in bariatric surgery patients.
